Skip to content

A practical view on the implementation of SRD II

It is almost one year since the adoption of the Belgian law implementing the Shareholder Rights Directive II (SRD II).
With SRD II came new rights and new opportunities for listed companies, but how can issuers benefit from this? 

Watch the exclusive webinar, brought to you by Euronext and Freshfields, where we will discuss, based on concrete experiences, the practical aspects of this new directive, its impact on activism, and how we can support you on these topics going forward.

View the webinar by clicking the 'Start Now' button.

Our speakers

Benoit Mathieu

Benoît Mathieu

Investor Relations Officer atMithra Pharmaceuticals


Deborah Janssens

Partner at Freshfields

Mathieu Mitevoy

Mathieu Mitevoy

Director Product Management at Euroclear Belgium


Nicolas Meunier

Head of Advisory and IR Solutions at Euronext Corporate Services

Benoit van den Hove Officiel

Benoît van den Hove

Job title at Company

Shareholder Rights Directive II (SRD II)

The objective of the SRD Il is to encourage long-term shareholder engagement, ensuring enhanced transparency and promoting discussions between issuers and investors. 

Among the provisions, this new directive allows issuers to identify their shareholder base.

  • How will SRD Il impact interactions between issuers and shareholders?

  • How will SRD Il interface with other provisions of Belgian law?

  • Performing a shareholder identification - the advantage of knowing your investors

  • Q&A Session


About Shareholder Analysis

Shareholder Analysis provides a comprehensive, dynamic and clear vision of your capital structure through several features:
  • Tailor-made identification

  • Multi-dimensional analysis

  • Enriched and detailed share register from local CSD

Sign up now !

Back to the top